These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25599612)

  • 81. Serum levels of adiponectin and IGFBP-1 in short children born small for gestational age.
    Kamoda T; Nozue H; Matsui A
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):290-4. PubMed ID: 17224001
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19).
    Wu X; Ge H; Lemon B; Vonderfecht S; Baribault H; Weiszmann J; Gupte J; Gardner J; Lindberg R; Wang Z; Li Y
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14158-63. PubMed ID: 20660733
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.
    Yu H; Xia F; Lam KS; Wang Y; Bao Y; Zhang J; Gu Y; Zhou P; Lu J; Jia W; Xu A
    Clin Chem; 2011 May; 57(5):691-700. PubMed ID: 21325103
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Insulin sensitivity in prematurely born adults: relation to preterm growth restraint.
    Rotteveel J; van Weissenbruch MM; Twisk JW; Delemarre-Van de Waal HA
    Horm Res Paediatr; 2011; 75(4):252-7. PubMed ID: 21135541
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Evaluation of lipid and glucose metabolism and cortisol and thyroid hormone levels in obese appropriate for gestational age (AGA) born and non-obese small for gestational age (SGA) born prepubertal Slovak children.
    Blusková Z; Koštálová L; Celec P; Vitáriušová E; Pribilincová Z; Maršálková M; Šemberová J; Kyselová T; Hlavatá A; Kovács L
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):693-9. PubMed ID: 24706427
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dual actions of fibroblast growth factor 19 on lipid metabolism.
    Wu X; Ge H; Baribault H; Gupte J; Weiszmann J; Lemon B; Gardner J; Fordstrom P; Tang J; Zhou M; Wang M; Li Y
    J Lipid Res; 2013 Feb; 54(2):325-32. PubMed ID: 23204296
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
    Wu X; Li Y
    Adv Exp Med Biol; 2012; 728():195-213. PubMed ID: 22396171
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
    Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
    Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hypersecretion of FSH in infant boys and girls born small for gestational age.
    Ibáñez L; Valls C; Cols M; Ferrer A; Marcos MV; De Zegher F
    J Clin Endocrinol Metab; 2002 May; 87(5):1986-8. PubMed ID: 11994329
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Potential roles of fibroblast growth factor 21 in the brain.
    Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
    [TBL] [Abstract][Full Text] [Related]  

  • 92. FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.
    Henriksson E; Andersen B
    Front Endocrinol (Lausanne); 2020; 11():601349. PubMed ID: 33414764
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under diet-induced obesity conditions.
    Ge H; Zhang J; Gong Y; Gupte J; Ye J; Weiszmann J; Samayoa K; Coberly S; Gardner J; Wang H; Corbin T; Chui D; Baribault H; Li Y
    J Biol Chem; 2014 Oct; 289(44):30470-30480. PubMed ID: 25204652
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Increased Fibroblast Growth Factor 21 (FGF21) Concentration in Early Second Trimester Amniotic Fluid and Its Association with Fetal Growth.
    Vrachnis N; Argyridis S; Vrachnis D; Antonakopoulos N; Valsamakis G; Iavazzo C; Zygouris D; Salakos N; Rodolakis A; Vlahos N; Mastorakos G; Drakakis P; Iliodromiti Z
    Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564397
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Fibroblast growth factor 21: a regulator of metabolic disease and health span.
    Xie T; Leung PS
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E292-E302. PubMed ID: 28559437
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
    Izaguirre M; Gil MJ; Monreal I; Montecucco F; Frühbeck G; Catalán V
    Curr Diab Rep; 2017 Jun; 17(6):43. PubMed ID: 28451950
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Fibroblast growth factor 21 - a key player in cardiovascular disorders?
    Lenart-Lipińska M; Duma D; Hałabiś M; Dziedzic M; Solski J
    Horm Mol Biol Clin Investig; 2016 Jun; 30(2):. PubMed ID: 27305706
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity.
    van Baak MA; Vink RG; Roumans NJT; Cheng CC; Adams AC; Mariman ECM
    Int J Obes (Lond); 2020 Feb; 44(2):544-547. PubMed ID: 31455871
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children.
    Seppä S; Tenhola S; Voutilainen R
    J Endocr Soc; 2019 Apr; 3(4):825-837. PubMed ID: 30963140
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
    Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.